A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2010-12-31
- Last Posted Date
- 2021-06-11
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 30
- Registration Number
- NCT01268527
- Locations
- 🇩🇪
Bioskin GmbH, Berlin, Germany
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias
- First Posted Date
- 2010-07-29
- Last Posted Date
- 2014-08-22
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 2
- Registration Number
- NCT01172379
- Locations
- 🇪🇸
Hospital Mutua de Terrassa, Terrassa, Spain
🇫🇷Centre D'Investigation Clinique Pavillon Riser - Hopital Purpan, Toulouse, France
🇩🇪Klinikum der Georg-August- Universit?t, G?ttingen, Germany
A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 66
- Registration Number
- NCT01146951
A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)
- First Posted Date
- 2010-06-04
- Last Posted Date
- 2016-01-25
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 144
- Registration Number
- NCT01136954
QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2012-04-13
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 26
- Registration Number
- NCT01106248
- Locations
- 🇫🇷
Medicale, Dunkerque, *CS, France
🇫🇷Service d'Oncologie, Dunkerque, *CS, France
Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (Bolus) Infusion of Eribulin in Patients With Advanced Solid Tumors
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2013-09-23
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 12
- Registration Number
- NCT01000376
- Locations
- 🇳🇱
The Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands
Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate
- First Posted Date
- 2008-07-11
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 2
- Registration Number
- NCT00713622
- Locations
- 🇫🇮
Kuopio University Hospital, Kuopio, Finland
🇦🇹Universitae Klinik fur Neurologiet, Innsbruck, Austria
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2015-12-24
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 10
- Registration Number
- NCT00693017
- Locations
- 🇦🇺
Strategic Health Evaluators Pty Ltd, Chatswood, New South Wales, Australia
🇦🇺The Prince of Wales Hospital, Randwick, New South Wales, Australia
ðŸ‡ðŸ‡ºVas County Markusovszky Hospital, Szombathely, Hungary
Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 21
- Registration Number
- NCT00692003
- Locations
- 🇨🇿
Fakultni nemocnice Plzen, Plzen, Czech Republic
🇪🇪West-Tallinn Central Hospital, Tallinn, Estonia
🇵🇱Wojewodzki Szpital Specjalistyczny im. M. Kopernika, Gdansk, Poland
The Effect of Vitamin K2 on Bone Turnover
- Conditions
- First Posted Date
- 2007-10-24
- Last Posted Date
- 2018-10-29
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 131
- Registration Number
- NCT00548509